Search the web
Welcome, Guest
[Sign Out, My Account]

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
ARGS > SEC Filings for ARGS > Form 8-K on 29-Jun-2016All Recent SEC Filings

Show all filings for ARGOS THERAPEUTICS INC



Other Events

Item 8.01 Other Events

On June 29, 2016, Argos Therapeutics, Inc. (the "Company") completed the closing of the second tranche of its private placement financing under the Company's previously announced March 2016 securities purchase agreement. In the closing of the second tranche, the Company sold, for a total purchase price of $29,824,520, a total of 5,478,672 shares of its common stock and warrants to purchase a total of 4,109,005 shares of its common stock (0.75 shares of common stock for each share of common stock purchased), based on a purchase price per share of common stock and accompanying warrant equal to $5.44375.

The closing of the second tranche was triggered by the previously announced recommendation from the Company's independent data monitoring committee ("IDMC") that the Company continue its pivotal Phase 3 ADAPT clinical trial of AGS-003 for the treatment of metastatic renal cell carcinoma based on results of the IDMC's scheduled interim data review.

  Add ARGS to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for ARGS - All Recent SEC Filings
Copyright © 2017 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.